GlassScriptPhysician profile
Barry Bk Chan
NPI 1114900826
$7,024.77
in general payments reported to CMS, 2019-2025
31 companies · $1,594 in 2025
The $1,594 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,303 · 2020: $449 · 2021: $827 · 2022: $1,108 · 2023: $616 · 2024: $1,128 · 2025: $1,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,338.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,156.15 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $1,142.79 | 2019-2025 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $962.87 | 2019-2025 | Atriclip Laa Exclusion System |
| Medtronic, INC. | $675.80 | 2024-2025 | Avalus, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $400.62 | 2019-2025 | Lifevest |
| Livanova USA, INC. | $334.67 | 2019 | |
| Abbott Laboratories | $310.43 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Epic |
| Saphena Medical, INC. | $237.00 | 2023 | Venapax |
| Clearflow INC. | $227.97 | 2019 | |
| Boston Scientific Corporation | $222.56 | 2023-2025 | Ekosonic, Watchman Flx |
| Corcym INC | $151.69 | 2021-2022 | |
| Shockwave Medical, INC | $138.54 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $121.62 | 2019 | |
| Janssen Pharmaceuticals, INC | $121.46 | 2019 | |
| La Jolla Pharmaceutical Company | $120.83 | 2025 | Giapreza |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $78.13 | 2022-2025 | Teg6s Hemostasis System |
| Kls-Martin L.P. | $66.03 | 2021 | |
| Novo Nordisk INC | $60.85 | 2024 | |
| Getinge USA Sales, LLC | $59.95 | 2019-2025 | Heartstring III Proximal Seal |
| Ethicon US, LLC | $58.20 | 2020-2023 | Surgicel Nu-Knit |
| Kestra Medical Technology Services, INC. | $54.06 | 2024-2025 | Assure Wcd |
| Lsi Solutions INC | $50.27 | 2022-2025 | Ram |
| Janssen Scientific Affairs, LLC | $49.96 | 2023 | Xarelto |
| Davol INC. | $44.01 | 2021 | |
| Cerus Corporation | $40.05 | 2022 | |
| Merz North America, INC. | $35.47 | 2020 | |
| Cvrx, INC. | $32.17 | 2023 | Barostim Neo System |
| Biom'Up Sa | $26.23 | 2019 | |
| Z-Medica, LLC | $15.67 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.76 | 2020 | |
| Abbvie INC. | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.